Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Dupilumab Therapy Modulates Circulating Inflammatory Mediators in Patients with Prurigo Nodularis

JID Innovations(2024)10.1016/j.xjidi.2024.100281Source: DataRank Database

Dupilumab Therapy Modulates Circulating Inflammatory Mediators in Patients with Prurigo Nodularis is a research paper published in JID Innovations (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 1.62)OA: goldTopics (21)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Emily Ma ORCID,Hannah Cornman ORCID,Anusha Kambala ORCID,Jaya Manjunath ORCID,Alexander Kollhoff ORCID

Live enrichment

PubMed:38947360 PMC:PMC11214504 OpenAlex:https://openalex.org/W4394770533

National Institutes of Health

Grant: K23AR077073-01A1

National Institute of Arthritis and Musculoskeletal and Skin Diseases

FWCI

1.62

Citation Percentile

0.8%

Citation Trend

2024

2025

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.xjidi.2024.100281

GOLDhttps://doi.org/10.1016/j.xjidi.2024.100281

publisherhttps://doi.org/10.1016/j.xjidi.2024.100281

publisherhttps://api.elsevier.com/content/article/PII:S2667026724000286?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2667026724000286?httpAccept=text/plain

Fields of Study

Dermatology and Skin DiseasesIL-33, ST2, and ILC PathwaysPsoriasis: Treatment and PathogenesisMedicine

Keywords

DupilumabPrurigo nodularisMedicineImmunologyInflammationImmune systemCytokineFibrosisImmune dysregulationInterleukin 23Atopic dermatitisInterleukin 17Internal medicineProteomicsPruritusBiologicsImmunomodulatory Therapy

Sustainable Development Goals

SDG 0: Good health and well-being